Featured OEL Fastrac Monograph: Fingolimod

Affygility Solutions is pleased to present our featured OEL Fastrac monograph for Fingolimod, Fingolimod is a human therapeutic indicated for the treatment of relapsing forms of multiple sclerosis. To find out more go to the Fingolimod OEL Fastrac page.

Occupational exposure limits and acceptable daily exposure values for pharmaceuticals

OEL Fastrac monographs offer the following benefits:

  • Save time! Unsurpassed delivery with instant download.
  • Expert preparation. Industry experts with advance degrees, professional certifications, and decades of experience.
  • Fully documented. 8-11 pages in length, with calculations and cited references.
  • High quality. Proprietary 18-point quality process.
  • Save money. Similar documents cost 5-12 times as much.
  • Stay current. Automatic notification of revisions.

For more information, and to browse our catalog of over 249 monographs, visit oelfastrac.com today!

Share and Enjoy:
  • Print
  • email
  • PDF
  • Twitter
  • LinkedIn
  • Google Buzz
  • del.icio.us
  • Digg
  • Posterous
  • Reddit
  • StumbleUpon
  • Propeller
  • Technorati

About Dean Calhoun

Dean is the President and CEO of Affygility Solutions. Affygility Solutions provides environmental, health and safety software, potent compound safety, industrial hygiene, containment validation services to the pharmaceutical, biotechnology, and medical device industry. "Dean's Google+ Profile"
This entry was posted in occupational toxicology, OEL Fastrac, potent compound safety. Bookmark the permalink.

Comments are closed.